Background Image
Table of Contents Table of Contents
Previous Page  215 / 302 Next Page
Information
Show Menu
Previous Page 215 / 302 Next Page
Page Background

5

Thermo Scienti c Poster Note

PN ASMS13_T589_Yang_E 07/13S

Conclusion

It is demonstrated that the co

software is a powerful tool in t

improved data quality, confide

the lack of a analytical standar

confirmation of non-targeted c

the false-identification of CEC

True positive identificati

compounds including p

compounds and environ

To achieve unambiguou

mass resolving power o

mm UHPLC column tha

maximum of 3–5 sec.

Identification by accurat

intensity of M/(M+1) can

ion(s), as suggested by

UHPLC information can

results.

References

1. “The Determination of E

by Liquid Chromatograp

Ministry of the Environm

laboratoryservicesbranc

2. “Method validation and

in food and feed” , Docu

Acknowledge

We would like to thank Dr. Vin

providing valuable suggestion

Splenda is a Registered trademark of

Microsoft Corporation. Waters is a trade

Fisher Scientific and its subsidiaries. Th

manner that might infringe the intellectu

Table 2 lists screening results of non-targeted compounds found in these 10 WWTP

samples along with their occurrence in both the positive and negative mode using the

312 CEC database. Of the 48 compounds in the top 10

th

percentile of area counts,

bisphenol A was the only one positively identified.

sis.

sing UHPLC-Orbitrap MS.

s accurate mass of the monoisotopic

ties of the M/(M+1) peaks and

anual inspection of line shape of the

mass spectrum will also improve the

ure 4 shows examples of true

common primary metabolite of the

containing xenobiotic 3,5-dibromo-4-

ner sucralose (Splenda®) (4C).

tification of desethylatrazine, an

. The mono-isotopic peak M has a

ect Gaussian shape and can be

mismatch of chlorine isotopic pattern

esethylatrazine.

1, PE #2, PE #2, SE #1, FE Permate Permate

952.5 4026.5 <MDL <MDL 105.0 <MDL

143.5 579.5 288.5 <MDL <MDL <MDL

<MDL 165.0 <MDL 3419.5 110.0 72.5

53.0 109.0 23.0 <MDL <MDL <MDL

426.5 <MDL 35.0 <MDL 288.0 105.5

<MDL <MDL <MDL <MDL <MDL <MDL

24.0 235.5 115.0 <MDL 262.0 183.5

304.5 319.5 315.0 298.5 606.5 536.0

<MDL 338.5 <MDL <MDL <MDL <MDL

<MDL 148.5 <MDL <MDL <MDL <MDL

8.0 11.0 9.5 <MDL 976.5 636.5

<MDL 118.5 54.5 <MDL 32.5 35.5

<MDL 125.5 49.0 <MDL <MDL <MDL

<MDL 957.5 <MDL <MDL 108.5 <MDL

211.0 1675.5 213.0 249.0 3621.5 3383.5

678.0 1531.0 1337.0 <MDL 1441.0 345.5

216.5 <MDL <MDL <MDL <MDL <MDL

174.0 125.0 77.5 127.0 260.0 227.0

237.0 166.5 170.0 196.0 159.5 159.5

176.5 532.0 247.5 411.0 <MDL <MDL

<MDL <MDL <MDL 343.5 777.5 912.0

ng/L

FIGURE 4

.

Examples of true-positive identification.

FIGURE 5

.

Example of a false-positive identification.

TABLE 2. Results of non-tar

Carbamazepine).

Compound Name

Benzotriazol

Methyl-Benzotriazol

N,N-Didesvenlafaxin

N-Desvenlafaxine

O-Desvenlafaxine

Tramadol

Venlafaxine

Lamotrigin

Metoprolol

Acridine

Dinoseb

n-Perfluorooctanoic acid

Galaxolidone

Nonylphenol monoethoxylate

Perfluorooctane sulfonate

Carbamazepine-10,11-epoxide

10,11-Epoxide-CBZ

OH-CBZ

Fenofibric-Acid

3-Phenoxybenzoic acid

Sucralose

Nonylphenol diethoxylate

Di-OH-CBZ

Perfluorohexane sulfonate

cted

B SPE

Grab sample collected in

1-L brown glass bottles

sis

Quantitative and non-targeted

analysis by TraceFinder software